SUBSCRIBE
SUBSCRIBE

Phase 1

Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Cambridge’s Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data
February 1, 2017
 · 
2 min read
For Sale: Pfizer's $3.4 Billion Consumer Healthcare Business
Drug Development
Pfizer Quietly Kills 3 Pipeline Programs
January 31, 2017
 · 
3 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
6 Biopharma Companies Face Catalysts in February
January 31, 2017
 · 
2 min read
Drug Development
Scientists Highlight the Hopes and Fears of Cellectis’ CAR-T
January 26, 2017
 · 
1 min read
Drug Development
Novartis AG Shows Off 13 Potential Blockbusters in Pipeline
January 25, 2017
 · 
1 min read
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
Drug Development
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
January 13, 2017
 · 
2 min read
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
Drug Development
JPM17: Secretive Moderna Finally Unveils Pipeline, Financials
January 10, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
Fortress Biotech Surged After Reporting Big Success With CAR-T Cancer Approach
December 29, 2016
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
4 Fatal Deaths in Seattle Genetics’ Early-Stage Trials of AML Drug
December 27, 2016
 · 
2 min read
Boston Scientific Commits to 10 More Years in SoCal Space, Plans to Hire
Drug Development
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017
December 22, 2016
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial
May 18, 2026
 · 
6 min read
Press Releases
Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial
May 18, 2026
 · 
3 min read
Press Releases
Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)
May 18, 2026
 · 
2 min read
Press Releases
SEED Therapeutics to Present Phase 1 Trial Design for ST-01156, a First-in-Human Oral RBM39 Molecular Glue Degrader, at 2026 ASCO Annual Meeting
May 18, 2026
 · 
3 min read
Press Releases
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
May 18, 2026
 · 
8 min read
Press Releases
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 18, 2026
 · 
4 min read
Press Releases
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy
May 18, 2026
 · 
2 min read
Press Releases
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
May 17, 2026
 · 
1 min read
Press Releases
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
May 17, 2026
 · 
9 min read
Press Releases
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 17, 2026
 · 
4 min read
Press Releases
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
May 15, 2026
 · 
13 min read
Press Releases
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101'
May 14, 2026
 · 
2 min read
Press Releases
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
May 14, 2026
 · 
7 min read
Press Releases
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
May 14, 2026
 · 
3 min read
Press Releases
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
May 14, 2026
 · 
11 min read
Press Releases
MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
May 14, 2026
 · 
6 min read
Press Releases
Forward Therapeutics Announces Completion of Phase 1 Trials with Two Internally Discovered Next-Generation TNF Signaling Inhibitors Supporting Advancement to Phase 2 Clinical Development
May 14, 2026
 · 
3 min read
Press Releases
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
May 14, 2026
 · 
18 min read
Press Releases
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
May 14, 2026
 · 
5 min read
Press Releases
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
 · 
11 min read
Load More